EDGAR Filing Documents for 0001104659-21-134438

Form F-3 - Registration statement by foreign private issuers:

SEC Accession No. 0001104659-21-134438

Filing Date

2021-11-04

Accepted

2021-11-04 16:58:42

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	F-3	tm2131851-1_f3.htm	F-3	800971
2	EXHIBIT 1.2	tm2131851d2_ex1-2.htm	EX-1.2	260719
3	EXHIBIT 5.1	tm2131851d2_ex5-1.htm	EX-5.1	35665
4	EXHIBIT 5.2	tm2131851d2_ex5-2.htm	EX-5.2	11988
5	EXHIBIT 5.3	tm2131851d2_ex5-3.htm	EX-5.3	36775
6	EXHIBIT 23.1	tm2131851d2_ex23-1.htm	EX-23.1	2362
7	GRAPHIC	lg_proqr-4c.jpg	GRAPHIC	33788
	Complete submission text file	0001104659-21-134438.txt		1196145

Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK

Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000

ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-260775 | Film No.: 211380920
SIC: 2834 Pharmaceutical Preparations